Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer

Breast Cancer

Volumn 19, Issue 4, 2012, Pages 321-328

  Fu, Peifen ^a,b   Ibusuki, Mutsuko ^a   Yamamoto, Yutaka ^a   Yamamoto, Satoko ^a   Fujiwara, Saori ^a   Murakami, Keiichi ^a   Zheng, Shusen ^b   Iwase, Hirotaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; Formalin fixed paraffin embedded tissue; Gene expression; Insulin like growth factor 1 receptor

Indexed keywords

MESSENGER RNA; SOMATOMEDIN C RECEPTOR; FORMALDEHYDE; PARAFFIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; FEASIBILITY STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC CORRELATION; HUMAN; HUMAN TISSUE; IGF1R GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; TUMOR INVASION; CRYOPRESERVATION; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; TISSUE FIXATION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CRYOPRESERVATION; FEMALE; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PARAFFIN EMBEDDING; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84876429234     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-011-0299-9     Document Type: Article

References (26)

1. Van't Veer LJ, Bernards J. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature. 2008;452:564-70. (Pubitemid 351483370)
2. Espinosa E, Vara JA, Redondo A, Sanchez JJ, Hardisson D, Zamora P, et al. Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study. J Clin Oncol. 2005;23:7278-85. (Pubitemid 46205951)
3. Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 1999;27:4436-43. (Pubitemid 29533185)
4. Ribeiro-Silva A, Zhang H, Jeffrey SS. RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies. BMC Mol Biol. 2007;8:118. (Pubitemid 351659655)
5. Jones RA, Campbell CI, Wood GA, Petrik JJ, Moorehead RA. Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene. 2009;28:2152-62.
6. Weroha SJ, Haluska P. IGF-1 receptor inhibitors in clinical trials - early lessons. J Mammary Gland Biol Neoplasia. 2008;13:471-83.
7. Chakraborty AK, Welsh A, Digiovanna MP. Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines. Breast Cancer Res Treat. 2010;120:327-35.
8. Fu P, Ibusuki M, Yamamoto Y, Hayashi M, Murakami K, Zheng S, et al. Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression. Breast Cancer Res Treat. doi: 10.1007/s10549-011-1605-0.
9. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol. 2003;21:3357-65. (Pubitemid 46606270)
10. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 2005;16:1569-83. (Pubitemid 41511089)
11. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133-44. (Pubitemid 47244357)
12. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internalcontrol genes. Genome Biol. 2002;3:RESEARCH0034.
13. Yamamoto Y, Ibusuki M, Okumura Y, Kawasoe T, Kai K, Iyama K, et al. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res Treat. 2008;110:465-75. (Pubitemid 351962589)
14. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med. 2010;134:907-22.
15. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287-312. (Pubitemid 350232263)
16. Toussaint J, Sieuwerts AM, Haibe-Kains B, Desmedt C, Rouas G, Harris AL, et al. Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues. BMC Genomics. 2009;10:424.
17. Esteva FJ, Sahin AA, Cristofanilli M, Coombes K, Lee SJ, Baker J, et al. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy. Clin Cancer Res. 2005;11:3315-9. (Pubitemid 40627881)
18. Specht K, Richter T, Muller U, Walch A, Werner M, Hofler H, et al. Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol. 2001;158:419-29. (Pubitemid 32158605)
19. Shin A, Ren Z, Shu XO, Cai Q, Gao YT, Zheng W, et al. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival. Breast Cancer Res Treat. 2007;105:55-61.
20. Neuhausen SL, Brummel S, Ding Y, Singer CF, Pfeiler G, Lynch HT, et al. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res. 2009;11:R76.
21. Li J, Smyth P, Cahill S, Denning K, Flavin R, Aherne S, et al. Improved RNA quality and TaqMan Pre-amplification method (PreAmp) to enhance expression analysis from formalin fixed paraffin embedded (FFPE) materials. BMC Biotechnol. 2008;8:10. (Pubitemid 351321285)
22. Muller BM, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, et al. Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue - a new option for predictive biomarker assessment in breast cancer. Diagn Mol Pathol. 2011;20:201-10.
23. Farragher SM, Tanney A, Kennedy RD, Euting H, Weber K, Bohmann K, et al. RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol. 2008;130:435-45.
24. Drury S, Anderson H, Dowsett M. Selection of reference genes for normalization of qRT-PCR data derived from FFPE breast tumors. Diagn Mol Pathol. 2009;18:103-7.
25. Sanchez-Navarro I, Gamez-Pozo A, Gonzalez-Baron M, Pinto-Marin A, Hardisson D, Lopez R, et al. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues. Biotechniques. 2010;48:389-97.
26. Lee AV, Hilsenbeck SG, Yee D. IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat. 1998;47:295-302. (Pubitemid 28059824)